Transdermal oxybutynin: a new treatment for overactive bladder.
about
Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladderAn overview of the clinical use of antimuscarinics in the treatment of overactive bladderOxybutynin topical gel in the treatment of overactive bladderThe medical treatment of overactive bladder, including current and future treatments.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial.
P2860
Transdermal oxybutynin: a new treatment for overactive bladder.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Transdermal oxybutynin: a new treatment for overactive bladder.
@ast
Transdermal oxybutynin: a new treatment for overactive bladder.
@en
type
label
Transdermal oxybutynin: a new treatment for overactive bladder.
@ast
Transdermal oxybutynin: a new treatment for overactive bladder.
@en
prefLabel
Transdermal oxybutynin: a new treatment for overactive bladder.
@ast
Transdermal oxybutynin: a new treatment for overactive bladder.
@en
P2860
P1476
Transdermal oxybutynin: a new treatment for overactive bladder.
@en
P2093
G Willy Davila
P2860
P304
P356
10.1517/14656566.4.12.2315
P407
P577
2003-12-01T00:00:00Z